Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases

Glycobiology

Volumn 27, Issue 4, 2017, Pages 318-328

  Arike, Liisa ^a   Holmén Larsson, Jessica ^a   Hansson, Gunnar C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Colon; Mass spectrometry; Mouse; Mucus; Small intestine

Indexed keywords

BACTERIAL ENZYME; BETA 1,3 GALACTOSYLTRANSFERASE; BETA 1,3 GALACTOSYLTRANSFERASE 5; BETA 1,3 N ACETYLGLUCOSAMINYLTRANSFERASE; BETA 1,4 GALACTOSYLTRANSFERASE; BETA 1,4 N ACETYLGALACTOSAMINYLTRANSFERASE 2; BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE 1; BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE 4; BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE 6; CHAPERONE; CORE PROTEIN; FUCOSYLTRANSFERASE; GLYCAN DERIVATIVE; GLYCOSYLTRANSFERASE; MUCIN 2; N ACETYLGLUCOSAMINYLTRANSFERASE; PEPTIDYLGALACTOSAMINYLTRANSFERASE 1; PEPTIDYLGALACTOSAMINYLTRANSFERASE 10; PEPTIDYLGALACTOSAMINYLTRANSFERASE 12; PEPTIDYLGALACTOSAMINYLTRANSFERASE 2; PEPTIDYLGALACTOSAMINYLTRANSFERASE 3; PEPTIDYLGALACTOSAMINYLTRANSFERASE 4; PEPTIDYLGALACTOSAMINYLTRANSFERASE 5; PEPTIDYLGALACTOSAMINYLTRANSFERASE 6; PEPTIDYLGALACTOSAMINYLTRANSFERASE 7; SIALYLTRANSFERASE; SULFOTRANSFERASE; SULFOTRANSFERASE 4; UNCLASSIFIED DRUG; MUC2 PROTEIN, MOUSE; POLYSACCHARIDE;

ARTICLE; ASCENDING COLON; BACTERIAL COLONIZATION; BIOSYNTHESIS; DESCENDING COLON; DUODENUM; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SYNTHESIS; GERMFREE MOUSE; ILEUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; JEJUNUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; SMALL INTESTINE; STOMACH MUCUS; ANIMAL; COLON; GENETICS; GLYCOSYLATION; INTESTINE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MOUSE;

ANIMALS; COLON; GASTROINTESTINAL MICROBIOME; GLYCOSYLATION; GLYCOSYLTRANSFERASES; INTESTINAL MUCOSA; INTESTINE, SMALL; INTESTINES; MICE; MUCIN-2; POLYSACCHARIDES;

EID: 85019540050     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cww134     Document Type: Article

References (42)

1. Asker N, Axelsson MAB, Olofsson SO, Hansson GC. 1998. Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the golgi apparatus. J Biol Chem. 273:18857-18863.
2. Atuma C, Strugala V, Allen A, Holm L. 2001. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol. 280:G922-G929.
3. Bennett EP, Hassan H, Hollingsworth MA, Clausen H. 1999. A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEBS Lett. 460:226-230.
4. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. 2012. Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 22:736-756.
5. Bergstrom K, Fu J, Johansson MEV, Liu X, Gao N, Wu Q, Song J, McDaniel JM, McGee S, Chen W et al. 2016. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice. Mucosal Immunol. 1-13.
6. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. 2011. Andromeda: A peptide search engine integrated into the MaxQuant environment. J Proteome Res. 10:1794-1805.
7. Dall'Olio F, Malagolini N, Chiricolo M, Trinchera M, Harduin-Lepers A. 2014. The expanding roles of the Sd(a)/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2. Biochim Biophys Acta. 1840:443-453.
8. Donaldson GP, Lee SM, Mazmanian SK. 2015. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 14:20-32.
9. Ermund A, Schütte A, Johansson MEV, Gustafsson JK, Hansson GC. 2013. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. Am J Physiol Gastrointest Liver Physiol. 305:G341-G347.
10. Gallien S, Duriez E, Crone C, Kellmann M, Moehring T, Domon B. 2012. Targeted proteomic quantification on Quadrupole-Orbitrap Mass Spectrometer. Mol Cell Proteomics. 11:1709-1723.
11. Geiger T, Velic A, Macek B, Lundberg E, Kampf C, Nagaraj N, Uhlen M, Cox J, Mann M. 2013. Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse. Mol Cell Proteomics. 12:1709-1722.
12. Goto Y, Obata T, Kunisawa J, Sato S, Ivanov II, Lamichhane A, Takeyama N, Kamioka M, Sakamoto M, Matsuki T et al. 2014. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science. 345:1254009-1-11.
13. Holmén JM, Olson FJ, Karlsson H, Hansson GC. 2003. Two glycosylation alterations of mouse intestinal mucins due to infection caused by the parasite Nippostrongylus brasiliensis. Glycoconj J. 19:67-75.
14. Holmén Larsson JM, Thomsson KA, Rodríguez-Piñeiro AM, Karlsson H, Hansson GC. 2013. Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution. Am J Physiol Gastrointest Liver Physiol. 305:G357-G363.
15. Johansson MEV, Jakobsson HE, Holmén-Larsson J, Schütte A, Ermund A, Rodríguez-Piñeiro AM, Arike L, Wising C, Svensson F, Bäckhed F et al. 2015. Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe. 18:1-11.
16. Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA. 105:15064-15069.
17. Ju T, Cummings RD. 2002. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci USA. 99:16613-16618.
18. Karlsson NG, Olson FJ, Jovall PA, Andersch Y, Enerback L, Hansson GC. 2000. Identification of transient glycosylation alterations of sialylated mucin oligosaccharides during infection by the rat intestinal parasite Nippostrongylus brasiliensis. Biochem J. 350:805-814.
19. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 40:189-197.
20. Kong Y, Joshi HJ, Schjoldager KT-BG, Madsen TD, Gerken TA, Vester-Christensen MB, Wandall HH, Bennett EP, Levery SB, Vakhrushev SY et al. 2015. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis. Glycobiology. 25:55-65.
21. Koropatkin NM, Cameron EA, Martens EC. 2012. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 10:323-335.
22. Larsson E, Tremaroli V, Lee YS, Koren O, Nookaew I, Fricker A, Nielsen J, Ley RE, Bäckhed F. 2012. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut. 61:1124-1131.
23. Larsson JMH, Karlsson H, Crespo JG, Johansson MEV, Eklund L, Sjövall H, Hansson GC. 2011. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis. 17:2299-2307.
24. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, MacCoss MJ. 2010. Skyline: An open source document editor for creating and analyzing targeted proteomics experiments. In: Bioinformatics. 26: 966-968.
25. Mahdavi J, Sondén B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson K-A et al. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science. 297:573-588.
26. Miller-Podraza H, Bergström J, Teneberg S, Milh MA, Longard M, Olsson BM, Uggla L, Karlsson KA. 1999. Helicobacter pylori and neutrophils: Sialic acid-dependent binding to various isolated glycoconjugates. Infect Immun. 67:6309-6313.
27. Milo R. 2013. What is the total number of protein molecules per cell volume? A call to rethink some published values. Bioessays. 35:1050-1055.
28. Olson FJ, Bäckström M, Karlsson H, Burchell J, Hansson GC. 2005. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase. Glycobiology. 15:177-191.
29. Post S, van der, Subramani DB, Bäckström M, Johansson MEV, Vester-Christensen MB, Mandel U, Bennett EP, Clausen H, Dahlén G, Sroka A et al. 2013. Site-specific O-glycosylation on the MUC2 mucin protein inhibits cleavage by the Porphyromonas gingivalis secreted cysteine protease (RgpB). J Biol Chem. 288:14636-14646.
30. Potapenko IO, Haakensen VD, Lüders T, Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC, Børresen-Dale A-L. 2010. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Mol Oncol. 4:98-118.
31. Rabot S, Membrez M, Bruneau A, Gérard P, Harach T, Moser M, Raymond F, Mansourian R, Chou CJ. 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 24:4948-4959.
32. Rappsilber J, Mann M, Ishihama Y. 2007. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2:1896-1906.
33. Revoredo L, Wang S, Bennett EP, Clausen H, Moremen KW, Jarvis DL, Ten Hagen KG, Tabak LA, Gerken TA. 2016. Mucin-type o-glycosylation is controlled by short- And long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family. Glycobiology. 26:360-376.
34. Rodríguez-Piñeiro AM, Bergström JH, Ermund A, Gustafsson JK, Johansson MEV, Hansson GC, Schuette A. 2013. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins - 2. Studies of mucus in mouse stomach, small intestine, and colon. Am J Physiol Gastrointest Liver Physiol. 305:G348-G356.
35. Sommer F, Adam N, Johansson MEV, Xia L, Hansson GC, Bäckhed F. 2014. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PLoS One. 9:85254-85254.
36. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466:707-713.
37. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, Gendler SJ, Hansson GC. 2002. Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucα1-2 glycosyltransferase. Biochem J. 367:609-616.
38. Thomsson KA, Holmén-Larsson JM, Angström J, Johansson MEV, Xia L, Hansson GC. 2012. Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. Glycobiology. 22:1128-1139.
39. Tran DT, Ten Hagen KG. 2013. Mucin-type O-glycosylation during development. J Biol Chem. 288:6921-6929.
40. van der Post S, Hansson GC. 2014. Membrane protein profiling of human colon reveals distinct regional differences. Mol Cell Proteomics. 13:2277-2287.
41. Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, Felin J, Perkins R, Borén J, Oresic M et al. 2010. The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res. 51:1101-1112.
42. Wiśniewski JR, Zougman A, Mann M. 2009. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res. 8:5674-5678.